Baumer (BOVESPA:BALM3) - Stock Price, News & Analysis

BALM3 Stock Overview

Develops solutions for health industry in Brazil. More details

BALM3 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	1/6
Financial Health	5/6
Dividends	2/6

Rewards

Trading at 74.3% below our estimate of its fair value

Risk Analysis

Earnings have declined by 1% per year over past 5 years

Shares are highly illiquid

Does not have a meaningful market cap (R$115M)

Profit margins (1.7%) are lower than last year (2.7%)

Baumer S.A. Competitors

Sincere

TSE:7782

JP¥3.3b

S.C. IOR

BVB:IORB

RON 129.2m

EPS Bio Technology

TPEX:4183

NT$541.5m

Profarma Distribuidora de Produtos Farmacêuticos

BOVESPA:PFRM3

R$827.6m

Price History & Performance

Summary of all time highs, changes and price drops for Baumer
Historical stock prices
Current Share Price	R$12.88
52 Week High	R$19.00
52 Week Low	R$9.90
Beta	0.35
11 Month Change	-0.23%
3 Month Change	3.04%
1 Year Change	32.10%
33 Year Change	-25.03%
5 Year Change	n/a
Change since IPO	414.17%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BALM3	BR Medical Equipment	BR Market
7D	-0.9%	0.9%	0.8%
1Y	32.1%	14.6%	-0.3%

Return vs Industry: BALM3 exceeded the BR Medical Equipment industry which returned 14.6% over the past year.

Return vs Market: BALM3 exceeded the BR Market which returned -0.3% over the past year.

Price Volatility

Is BALM3's price volatile compared to industry and market?
BALM3 volatility
BALM3 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.0%
Market Average Movement	4.5%
10% most volatile stocks in BR Market	8.2%
10% least volatile stocks in BR Market	2.3%

Stable Share Price: BALM3's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine BALM3's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1952	n/a	Ruy Salvari Baumer	www.baumer.com.br

Baumer S.A. develops solutions for health industry in Brazil. It offers environment monitor, an electronic system that monitors particles suspended in air PM10 and PM2.5, which includes temperature, relative humidity, concentration of carbon dioxide and chemical pollutants, environmental noise intensity, lighting conditions, presence of people and animals, and relative pressure. The company also provides Purafog, a web and dry nebulization; PuraVac; mini purifies; and dental solutions, such as bone graft and membrane solutions.

Baumer S.A. Fundamentals Summary

How do Baumer's earnings and revenue compare to its market cap?
BALM3 fundamental statistics
Market cap	R$114.76m
Earnings (TTM)	R$3.00m
Revenue (TTM)	R$178.51m

34.5x

P/E Ratio

0.6x

P/S Ratio

Is BALM3 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BALM3 income statement (TTM)
Revenue	R$178.51m
Cost of Revenue	R$68.92m
Gross Profit	R$109.59m
Other Expenses	R$106.60m
Earnings	R$3.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.31
Gross Margin	61.39%
Net Profit Margin	1.68%
Debt/Equity Ratio	10.7%

How did BALM3 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

43%

Payout Ratio

Does BALM3 pay a reliable dividends?

See BALM3 dividend history and benchmarks

When do you need to buy BALM3 by to receive an upcoming dividend?
Baumer dividend dates
Ex Dividend Date	Dec 06 2023
Dividend Pay Date	Dec 27 2024
Days until Ex dividend	354 days
Days until Dividend pay date	33 days

Does BALM3 pay a reliable dividends?

See BALM3 dividend history and benchmarks